Main Article Content

Abstract

An atrial myxoma is a noncancerous tumor in the upper left or right side of the heart. It grows on the wall that separates the two sides of the heart. This wall is called the atrial septum. Atrial myxomas are the most common primary heart tumours. It usually arises as a polypoid, gelatinous structure attached by a pedicle to the left atrium. Myxomas may arise less commonly in the right atrium or the ventricles. From an epidemiologic perspective, cardiac myxomas are divided into the following 2 categories, those that arise sporadically (non-familial myxomas), which account for about 95% of cases, and those that occur in association with a so-called myxoma syndrome (familial myxomas), which account for about 5%. Sudden death may occur in 15% patients with atrial myxoma. Sporadic cardiac myxomas occur approximately twice as often in women as in men. The exact origin of myxoma cells remains uncertain, but they are thought to arise from remnants of subendocardial cells or Multipotential mesenchymal cells in the region of the fossa ovalis, which can differentiate along a variety of cell lines. Signs and symptoms of mitral stenosis, endocarditis, mitral regurgitation, and collagen vascular disease can simulate those of atrial myxoma. The treatment of choice for myxomas is surgical removal. It is usually curative. After the diagnosis has been established, surgery should be performed promptly because of possibility of embolic complications or sudden death. The aim of this review is to find the cause, symptoms and treatment of atrial myxoma, also to make the aware of atrial myxoma.

Keywords

Atrial myxoma Sneddon syndrome Fossa ovalis PRKAR1α Pluripotential stem cell Tumor plop

Article Details

How to Cite
Mr. Jeeva James, Shyni J.R, & Dr. Sujith Abraham. (2021). A comprehensive review on atrial myxoma. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(3), 272-280. https://doi.org/10.61096/ijrpp.v6.iss3.2017.272-280

References

  1. [1]. Braunwald Fauci, Kasper Hauser, Longo Jameson. Disorders of cardiovascular system: Cardiac tumours, cardiac manifestations of systemic disease. Harrison’s Principles of Internal Medicine. 15, 2001, 1372–1374.
  2. [2]. Larry A. Weinrauch, MD, Assistant Professor of Medicine, Harvard Medical School, and Private practice specializing in Cardiovascular Disease, Watertown, MA. Review provided by VeriMed Healthcare Network.Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
  3. [3]. King TW. On simple vascular growths in the left auricle of the heart. Lancet, 2, 1845, 428
  4. [4]. Knepper LE, Biller J, Adams HP, Bruno A. Neurologic manifestations of atrial myxoma. a 12-year experience and review of Stroke.1988, 19, 1435-1440.
  5. [5]. McManus B, Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Edn 9th. Philadelphia, 2011, 74.
  6. [6]. Griffiths GC. A review of primary tumors of the heart. Progressive Cardiovascular Disorders.7, 1965, 465-479.
  7. [7]. Crafoord C, Glover RP, Lam CR. The development of cardiovascular surgery. J cardiovasc surg. 5(6), 1965, 1-12.
  8. [8]. Greeson DM, Wright JE, Zanolli MD, Cutaneous findings associated with cardiac myxomas.Cutis. 62, 1998, 275-280.
  9. [9]. Schellong SM, Weissenborn K, Niedermeyer J. Classification of Sneddon's syndrome. Vasa. 26(3), 1997, 215-221.
  10. [10]. Zheng JJ, Geng XG, Wang HC, Yan Y, Wang HY. Clinical and histopathological analysis of 66 cases with cardiac myxoma. Asian Pac J Cancer. 14(3), 2013, 1743-1749.
  11. [11]. .Aggarwal SK, Barik R, Sarma TC, Iyer VR, Sai V, Mishra J. Clinical presentation and investigation findings in cardiac myxomas: new insights from the developing world. Am Heart J. 154(6), 2007, 1102-1107.
  12. [12]. Bulkley BH, Hutchins GM. Atrial myxomas: a fifty year review. Am Heart J. 97, 1979, 639-643.
  13. [13]. Hovels-Gurich HH, Seghaye MC, Amo-Takyi BK, Hugel W, Duchateau J, von Bernuth G. Cardiac myxoma in a 6-year-old child-- constitutional symptoms mimicking rheumatic disease and the role of interleukin-6. Acta Paediatr. 88, 1999, 786-788.
  14. [14]. Shapiro LM. Cardiac tumours: diagnosis and management. Am Heart J. 85, 2001, 218-222.
  15. [15]. Sakamoto H, Sakamaki T, Sumino H. Production of endothelin- 1 and big endothelin-1 by human cardiac myxoma cells-implications of the origin of myxomas. Circ J 68(12), 2004, 1230-1232.
  16. [16]. Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J. 140, 2000, 134-138.
  17. [17]. Orlandi A, Ciucci A, Ferlosio A, Genta R, Spagnoli LG, Gabbiani G. Cardiac myxoma cells exhibit embryonic endocardial stem cell features. J Pathol . 209(2), 2006, 231-239.
  18. [18]. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine. 64, 1985, 270-283.
  19. [19]. http://bestpractice.bmj.com/best-practice/monograph/1054/basics/pathophysiology.html
  20. [20]. Reyaz A. Lone, A G Ahanger,Wani Lateef.Atrial myxoma trends in management. International journal of health sciences. 2(2), 2008, 141–151.
  21. [21]. Jelic J, Milicic D, Alfirevic I. Cardiac myxoma: diagnostic approach, surgical treatment and follow-up. A twenty years experience. J Cardiovasc Surg. 37(6), 1996, 113.
  22. [22]. Nasser wk, David rh, Dillon jc, et al: Atrial myx-oma. I. Clinical and pathologic features in nine cases. Am Heart J. 83, 1972, 694.
  23. [23]. Prieto Macias J, Orea Tejeda A, Santiago Bravo M, et al. Left atrial myxoma causing severe mitral valve occlusion. Arch Inst Cardiol Mex . 59(6), 1989, 611-614.
  24. [24]. Lijoi A, Scoti, P, Faveto, C, et al Surgical management of intracardiac myxomas: a 16 year experience.Tex Heart Inst J. 20, 1993, 231-234.
  25. [25]. Scott N, Veinot JP, Chan KL. Symptoms in cardiac myxoma. Chest J. 124(6), 2003, 2408.
  26. [26]. MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, et al. Atrial myxoma: national incidence, diagnosis and surgical management. Ir J Med Sci. 162(6), 1993, 223-226.